Ehave Expands Its Psychedelic Mental Health Platform with Medchart, a Leader in Medical Record Software, as a Plugin to the Ehave Dashboard MIAMI, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to healthcare patients,...

PsyTech Hosts Live Investor Conference & Webinar October 27, 2020 and Closes Transaction with One of the Largest Psychedelic Conferences PsyTech.biz PsyTech Summit 2020 will be a one-day, international event bringing together decision makers, investors, clinicians, thought leaders, and advocates for the purpose of advancing psychedelics science,...

Ehave, Inc. Launches Premier Psychedelic Retreat Centers Partnership and MyLifeID Card Giveaway MIAMI, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients,...

FDA Approves Akili Video Game for Kids With ADHD as Prescription Treatment Opening Door for Ehave to Pursue Clearance for its MegaTeam Products MIAMI, June 18, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced...